Back to Search
STEPHEN NISSEN, PHARMD
PHARMD
Critical Care Pharmacist
NPI: 1770930307Individual
Specialties, Licenses & Credentials
Critical Care PharmacistPrimary
Pharmacist — Critical Care
Code: 1835C0205X
11240(NE)
Research & Publications (20)
The vulnerable plaque "hypothesis": promise, but little progress.
PMID 19580732·JACC Cardiovasc Imaging·2009
8-other
The Jupiter trial: key findings, controversies, and implications.
PMID 19236822·Curr Cardiol Rep·2009
8-other
Rationale for cardiovascular medicine to separate from internal medicine and become an independent specialty.
PMID 18950550·Curr Cardiol Rep·2008
8-other
ENHANCE and ACCORD: controversy over surrogate end points.
PMID 18489856·Curr Cardiol Rep·2008
8-other
A much-anticipated FDA reform bill is signed into law: progress and compromise.
PMID 18445347·Curr Diab Rep·2008
8-other
Courage under fire: what is the optimal approach to initial treatment of stable angina?
PMID 18417006·Curr Cardiol Rep·2008
8-other
A much-anticipated FDA reform bill is signed into law: progress and compromise.
PMID 18416992·Curr Cardiol Rep·2008
8-other
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial.
PMID 18387931·JAMA·2008
4-observational
Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.
PMID 18378631·JAMA·2008
4-observational
Perspective: effect of rosiglitazone on cardiovascular outcomes.
PMID 17877927·Curr Cardiol Rep·2007
8-other
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.
PMID 17517853·N Engl J Med·2007
1-meta
Effect of torcetrapib on the progression of coronary atherosclerosis.
PMID 17387129·N Engl J Med·2007
4-observational
Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials.
PMID 17384435·JAMA·2007
4-observational
Effect of ACAT inhibition on the progression of coronary atherosclerosis.
PMID 16554527·N Engl J Med·2006
3-trial
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.
PMID 16533939·JAMA·2006
3-trial
Halting the progression of atherosclerosis with intensive lipid lowering: results from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.
PMID 16356804·Am J Med·2005
4-observational
Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.
PMID 16239637·JAMA·2005
8-other
Report from the Cardiovascular and Renal Drugs Advisory Committee: US Food and Drug Administration; June 15-16, 2005; Gaithersburg, Md.
PMID 16186439·Circulation·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4101 WOOLWORTH AVE
OMAHA, NE 68105 - Phone
- (402) 995-3890
Quick Facts
- NPI
- 1770930307
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile